Table: begin end state 1 15 non-cytoplasmic 16 34 transmembrane 35 79 cytoplasmic 80 100 transmembrane 101 119 non-cytoplasmic 120 141 transmembrane 142 157 cytoplasmic 158 177 transmembrane 178 189 non-cytoplasmic 190 205 transmembrane 206 207 non-cytoplasmic 208 216 cytoplasmic 217 235 transmembrane 236 662 non-cytoplasmic
Input: >WP_012501363.1 NCBI__GCF_000020505.1:WP_012501363.1 MEATREIYWNIDHGTVALMYLMALAAVAVMVYGFRERIALWQKGKSLDRFDHLQQRLAHF ITDALSQRKVLNVMQGGLPHALLFWGFLLLFIGTVLVMLQADLLAPLFSVNLLSGDFYRL YSFVLDLAGLAAMLALAALAVRRFIIKPAGLETSSADVAIHLLLFAILFSGFLIEGARMA VTEVRDNPALAAWSPVGAVFARPFLGMDEHLVRGAHKGFWLLHLLFGLGFLAVIPRTKLR HLATTSGGSLLEPHEPTGTYSAIDLEDEHIEQFGASVVSDLSWKDLFDTDACMQCGRCQQ RCPAHLTGKPLSPMKVITDIGELAGNENGKGLVEKVSRDALWSCTTCRACEQICPASIEH IGKIIEMRRSLALMEGEFPGDEARRACEAIEVNGNPFGLSATSRGDWAKGLPVSIIKGKC DADILYFTGCYASHDPRNRKVAESFVRICEAAGVTVAILGGAERCCGEPARKLGNEYLYR MVADSNIEAIRASGARRIVTACPHCFNTLARDYRELGLDLPVEHHSTFIARLINDGKLKL KPERFTATFHDSCYLARYQEIAEEPREVVRAAGIKLVEMAAFGKNGFCCGAGGGRILAEE KLGTPIVDERLRQARQTGAKSLVSACPFCLSMFEDGLKRADSREPIKAYDLAEIVARSID RK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server